BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8492762)

  • 1. Microdosimetric concepts in radioimmunotherapy.
    Humm JL; Roeske JC; Fisher DR; Chen GT
    Med Phys; 1993; 20(2 Pt 2):535-41. PubMed ID: 8492762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytic microdosimetry for radioimmunotherapeutic alpha emitters.
    Stinchcomb TG; Roeske JC
    Med Phys; 1992; 19(6):1385-93. PubMed ID: 1461200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental radioimmunotherapy.
    Buchsbaum DJ; Langmuir VK; Wessels BW
    Med Phys; 1993; 20(2 Pt 2):551-67. PubMed ID: 8492764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different classes of radionuclides for potential use in radioimmunotherapy.
    Karagiannis TC
    Hell J Nucl Med; 2007; 10(2):82-8. PubMed ID: 17684582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiobiology of radiolabeled antibody therapy as applied to tumor dosimetry.
    Langmuir VK; Fowler JF; Knox SJ; Wessels BW; Sutherland RM; Wong JY
    Med Phys; 1993; 20(2 Pt 2):601-10. PubMed ID: 8492769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
    Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Begent RH
    Cancer Biother Radiopharm; 2001 Oct; 16(5):391-400. PubMed ID: 11776756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
    Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
    Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-particle microdosimetry.
    Chouin N; Bardies M
    Curr Radiopharm; 2011 Jul; 4(3):266-80. PubMed ID: 22201713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted alpha therapy: part I.
    Elgqvist J
    Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor dosimetry in radioimmunotherapy: methods of calculation for beta particles.
    Leichner PK; Kwok CS
    Med Phys; 1993; 20(2 Pt 2):529-34. PubMed ID: 8492761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of red marrow radiation dosimetry with myelotoxicity: empirical factors influencing the radiation-induced myelotoxicity of radiolabeled antibodies, fragments and peptides in pre-clinical and clinical settings.
    Behr TM; Béhé M; Sgouros G
    Cancer Biother Radiopharm; 2002 Aug; 17(4):445-64. PubMed ID: 12396708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes.
    Rajendran JG; Fisher DR; Gopal AK; Durack LD; Press OW; Eary JF
    J Nucl Med; 2004 Jun; 45(6):1059-64. PubMed ID: 15181141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internal microdosimetry of alpha-emitting radionuclides.
    Hofmann W; Li WB; Friedland W; Miller BW; Madas B; Bardiès M; Balásházy I
    Radiat Environ Biophys; 2020 Mar; 59(1):29-62. PubMed ID: 31863162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internal microdosimetry for single cells in radioimmunotherapy of B-cell lymphoma.
    Hindorf C; Emfietzoglou D; Lindén O; Kostarelos K; Strand SE
    Cancer Biother Radiopharm; 2005 Apr; 20(2):224-30. PubMed ID: 15869460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationales, evidence, and design considerations for fractionated radioimmunotherapy.
    DeNardo GL; Schlom J; Buchsbaum DJ; Meredith RF; O'Donoghue JA; Sgouros G; Humm JL; DeNardo SJ
    Cancer; 2002 Feb; 94(4 Suppl):1332-48. PubMed ID: 11877764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetry of intraperitoneally administered radiolabeled antibodies.
    Roeske JC; Chen GT; Brill AB
    Med Phys; 1993; 20(2 Pt 2):593-600. PubMed ID: 8492768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internal dosimetry using data derived from autoradiographs.
    Humm JL; Macklis RM; Bump K; Cobb LM; Chin LM
    J Nucl Med; 1993 Oct; 34(10):1811-7. PubMed ID: 8410302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides.
    Goddu SM; Rao DV; Howell RW
    J Nucl Med; 1994 Mar; 35(3):521-30. PubMed ID: 8113908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetry models for radioimmunotherapy.
    Langmuir VK; Sutherland RM
    Med Phys; 1988; 15(6):867-73. PubMed ID: 3237144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.